I agree that this site is using cookies. You can find further informations here.
X
Mellenthin, Claudia
24  results:
Search for persons X
?
1

Risk Factors for Pancreatic Cancer in Patients with New-Ons..:

Mellenthin, Claudia ; Balaban, Vasile Daniel ; Dugic, Ana.
Cancers.  14 (2022)  19 - p. 4684 , 2022
Link: https://doi.org/10.3390/..
 
?
2

The Clinical Utility of Soluble Serum Biomarkers in Autoimm..:

Dugic, Ana ; Verdejo Gil, Cristina ; Mellenthin, Claudia...
Biomedicines.  10 (2022)  7 - p. 1511 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Fructose-induced severe hypertriglyceridemia and diabetes m..:

Dugic, Ana ; Kryk, Michael ; Mellenthin, Claudia...
Endocrinology, Diabetes & Metabolism Case Reports.  2021 (2021)  - p. , 2021
Link: https://doi.org/10.1530/..
 
?
4

Therapeutic targeting of STAT3 pathways in pancreatic adeno..:

Peisl, Sarah ; Mellenthin, Claudia ; Vignot, Lucie...
PLOS ONE.  16 (2021)  6 - p. e0252397 , 2021
Link: https://doi.org/10.1371/..
 
?
5

Patient-Reported Outcome Measures in Colorectal Surgery: Co..:

El-Hussuna, Alaa ; Rubio-Perez, Ines ; Millan, Monica...
Surgical Innovation.  28 (2021)  5 - p. 560-566 , 2021
Link: https://doi.org/10.1177/..
 
?
6

HFE mutations and chronic hepatitis C: H63D and C282Y heter..:

Erhardt, Andreas ; Maschner-Olberg, Andrea ; Mellenthin, Claudia...
Journal of Hepatology.  38 (2003)  3 - p. 335-342 , 2003
Link: https://doi.org/10.1016/..
 
?
7

The Clinical Utility of Soluble Serum Biomarkers in Autoimm..:

Dugic, Ana ; Verdejo Gil, Cristina ; Mellenthin, Claudia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312496/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

The Clinical Utility of Soluble Serum Biomarkers in Autoimm..:

Dugic, Ana ; Verdejo Gil, Cristina ; Mellenthin, Claudia...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/19802.  , 2022
Link: https://opus4.kobv.de/op..
 
?
9

Risk Factors for Pancreatic Cancer in Patients with New-Ons..:

Mellenthin, Claudia ; Balaban, Vasile Daniel ; Dugic, Ana.
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/20290.  , 2022
Link: https://opus4.kobv.de/op..
 
?
10

Fructose-induced severe hypertriglyceridemia and diabetes m..:

Dugic, Ana ; Kryk, Michael ; Mellenthin, Claudia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630754/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

The Clinical Utility of Soluble Serum Biomarkers in Autoimm..:

Ana Dugic ; Cristina Verdejo Gil ; Claudia Mellenthin...
https://www.mdpi.com/2227-9059/10/7/1511.  , 2022
Link: https://doi.org/10.3390/..
 
?
12

The Clinical Utility of Soluble Serum Biomarkers in Autoimm..:

Ana Dugic ; Cristina Verdejo Gil ; Claudia Mellenthin...
Immunology and Immunotherapy.  , 2022
Link: https://doi.org/10.3390/..
 
?
13

Risk Factors for Pancreatic Cancer in Patients with New-Ons..:

Claudia Mellenthin ; Vasile Daniel Balaban ; Ana Dugic.
Methods and Technologies Development.  , 2022
Link: https://doi.org/10.3390/..
 
?
14

Risk Factors for Pancreatic Cancer in Patients with New-Ons..:

Claudia Mellenthin ; Vasile Daniel Balaban ; Ana Dugic.
https://www.mdpi.com/2072-6694/14/19/4684.  , 2022
Link: https://doi.org/10.3390/..
 
?
15

Fructose-induced severe hypertriglyceridemia and diabetes m..:

Ana Dugic ; Michael Kryk ; Claudia Mellenthin...
https://edm.bioscientifica.com/view/journals/edm/2021/1/EDM21-0110.xml.  , 2021
Link: https://doi.org/10.1530/..
 
1-15